MULTIDIRECTIONAL DIFFERENTIATION IN A NEWLY ESTABLISHED HUMAN EPITHELIOID SARCOMA CELL-LINE (GRU-1) WITH CO-EXPRESSION OF VIMENTIN, CYTOKERATINS AND NEUROFILAMENT PROTEINS

被引:30
作者
GERHARZ, CD [1 ]
MOLL, R [1 ]
RAMP, U [1 ]
MELLIN, W [1 ]
GABBERT, HE [1 ]
机构
[1] UNIV MUNSTER,DEPT PATHOL,W-4400 MUNSTER,GERMANY
关键词
D O I
10.1002/ijc.2910450126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A new permanent cell line (GRU‐1) derived from the lymph‐node metastasis of a human epithelioid sarcoma was established in tissue culture. Immunohistochemically, the original tumor had exhibited an intriguing potential for multidirectional differentiation with features of mesenchymal, epithelial and neural differentiation, evidenced by the co‐expression of vimentin, cytokeratins and neurofilament proteins, respectively. This capability for multidirectional differentiation was fully preserved in the cultured cells. GRU‐1 tumor cells proved to be uniformly positive for vimentin and a considerable proportion of the tumor cells exhibited a positive reaction for cytokeratins and neurofilament proteins. The neural markers neuron‐specific enolase (NSE) and synaptophysin were observed in a small proportion of GRU‐1 cells. Ultrastructurally, GRU‐1 cells showed desmoplastic activity in vitro, being enmeshed by collagen fibrils. DNA distribution, as studied by flow cytophotometry, revealed DNA‐diploidy (DNA index =1) and a G0/G1‐proportion of 70.5%. After heterotransplantation in nude mice, GRU‐1 tumor cells expressed vimentin and cytokeratin only, whereas the neural markers could not be further demonstrated. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:143 / 152
页数:10
相关论文
共 50 条
[1]   EXPRESSION OF GLIAL FILAMENT PROTEIN (GFP) IN NERVE SHEATHS AND NONNEURAL CELLS REEXAMINED USING MONOCLONAL-ANTIBODIES, WITH SPECIAL EMPHASIS ON THE COEXPRESSION OF GFP AND CYTOKERATINS IN EPITHELIAL-CELLS OF HUMAN SALIVARY-GLAND AND PLEOMORPHIC ADENOMAS [J].
ACHTSTATTER, T ;
MOLL, R ;
ANDERSON, A ;
KUHN, C ;
PITZ, S ;
SCHWECHHEIMER, K ;
FRANKE, WW .
DIFFERENTIATION, 1986, 31 (03) :206-227
[2]   EPITHELIOID SARCOMA - A TUMOR OF MYOFIBROBLASTS [J].
BLEWITT, RW ;
APARICIO, SGR ;
BIRD, CC .
HISTOPATHOLOGY, 1983, 7 (04) :573-584
[3]  
BLOUSTEIN PA, 1976, CANCER-AM CANCER SOC, V38, P2390, DOI 10.1002/1097-0142(197612)38:6<2390::AID-CNCR2820380627>3.0.CO
[4]  
2-F
[5]   CYTOKERATIN EXPRESSION IN SMOOTH-MUSCLE AND SMOOTH-MUSCLE TUMORS [J].
BROWN, DC ;
THEAKER, JM ;
BANKS, PM ;
GATTER, KC ;
MASON, DY .
HISTOPATHOLOGY, 1987, 11 (05) :477-486
[6]   KERATIN IN EPITHELIOID SARCOMA - AN IMMUNOHISTOCHEMICAL STUDY [J].
CHASE, DR ;
ENZINGER, FM ;
WEISS, SW ;
LANGLOSS, JM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1984, 8 (06) :435-441
[7]   EPITHELIOID SARCOMA - DIAGNOSIS, PROGNOSTIC INDICATORS, AND TREATMENT [J].
CHASE, DR ;
ENZINGER, FM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1985, 9 (04) :241-263
[8]   IMMUNOHISTOCHEMICAL STUDY OF RHABDOMYOSARCOMA - UNEXPECTED STAINING WITH S100 PROTEIN AND CYTOKERATIN [J].
COINDRE, JM ;
DEMASCAREL, A ;
TROJANI, M ;
DEMASCAREL, I ;
PAGES, A .
JOURNAL OF PATHOLOGY, 1988, 155 (02) :127-132
[9]  
DAIMARU Y, 1987, CANCER, V59, P131
[10]   MATHEMATICAL-ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY [J].
DEAN, PN ;
JETT, JH .
JOURNAL OF CELL BIOLOGY, 1974, 60 (02) :523-527